Review of the Protective Mechanism of Paeonol on Cardiovascular Disease
Chunkun Yang,Jiawen Cheng,Qinwei Zhu,Qingquan Pan,Kui Ji,Jun Li
DOI: https://doi.org/10.2147/DDDT.S414752
2023-07-27
Abstract:Chunkun Yang, 1, &ast Jiawen Cheng, 1, &ast Qinwei Zhu, 2 Qingquan Pan, 2 Kui Ji, 2 Jun Li 1 1 Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China; 2 Department of Emergency, Weifang Hospital of Traditional Chinese Medicine, Weifang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jun Li, Email Cardiovascular disease (CVD) is one of the leading causes of death in the world. Paeonol(Pae) is a phenolic component extracted from peony bark, peony root and Xu Changqing. Studies have shown that Pae can protect cardiomyocytes by inhibiting oxidative stress, promoting mitochondrial fusion, regulating mitochondrial autophagy and inhibiting inflammation. In addition, Pae improves ventricular remodeling by inhibiting myocardial apoptosis, hypertrophy and fibrosis. Pae also has a good protective effect on blood vessels by inhibiting vascular inflammation, reducing the expression of adhesion molecules, inhibiting vascular proliferation, and inhibiting oxidative stress and endoplasmic reticulum stress(ERS). Pae also has the effect of anti-endothelial cell senescence, promoting thrombus recanalization and vasodilating. In conclusion, the molecular targets of Pae are very complex, and the relationship between different targets and signaling pathways cannot be clearly explained, which requires us to use systems biology methods to further study specific molecular targets of Pae. It has to be mentioned that the bioavailability of Pae is poor, and some nanotechnology-assisted drug delivery systems improve the therapeutic effect of Pae. We reviewed the protective mechanism of paeonol on the cardiovascular system, hoping to provide help for drug development in the treatment of CVD. Keywords: paeonol, oxidative stress, inflammation, mitochondrial fusion, adhesion, autophagy With the change of living habits and environment, the spectrum of human diseases is also gradually changing.Epidemiological studies have shown that with the ageing of the population, increasing environmental pollution and poor lifestyle habits, all contribute to chronic diseases, especially cardiovascular diseases, which are the major causes of morbidity and mortality worldwide. 1 Cardiovascular disease (CVD) has become one of the leading causes of death in the world.The World Health Organization estimates that 30,000 people die every day from CVD and that more than 40% of non-communicable disease deaths each year are attributed to CVD. 2 Paeonol (Pae) is a phenolic component extracted from peony bark, paeonia rubra and Xu Changqing. It has a wide range of biological activities, including antioxidant, anti-inflammatory, anti-cancer and apoptosis inhibition. 3 In recent years, studies have shown that Pae has a good protective effect on the cardiovascular system. In China, Pae is used alone or in combination with other traditional Chinese medicines to effectively protect the cardiovascular system, suggesting that Pae may be used as an alternative or supplement to compensate for the limited efficiency of modern drugs in treating CVD. A previous paper 4 on advances in the bioactivity of Pae in CVD was published in 2021, but this paper included only 20 basic studies. When writing this review, we searched relevant studies in CNKI and pubmed, including a total of 57 basic studies on Pae's improvement of CVD. In this review, we have more comprehensively summarized the improvement mechanism of Pae on CVD (Figure 1). Figure 1 ( a ) Peony bark. ( b ) Xu Changqing. ( c ) Paeonia rubra. ( d ) Chemical structure of Paeonol. ( e and f ) Pharmacological effects of Paeonol. Myocardial ischemia/reperfusion (I/R) injury is a significant clinical problem, resulting in increased production of reactive oxygen species (ROS), lipid peroxidation of myocardial membrane, inactivation of key enzymes, and interference with nucleic acid synthesis. This leads to dysfunction of heart muscle cells. 5 Breast cancer type 1 sensitive protein (BRCA1) gene, as a regulator of genomic stability, is involved in DNA repair and transcription. 6 BRCA1 has been shown to protect vascular smooth muscle cells (VSMC) from oxidative stress. 7 Zheng et al found that after myocardial anoxia/reoxygenation (A/R) injury, Pae (10 μM) can improve the activity of antioxidant enzymes and reduce the production of ROS by up-regulating the expression of BRCA1. Zheng et al 8 found that after myocardial A/R injury, Pae (10 μM) can improve the activity of antioxidant enzymes and reduce the production of ROS by up-reg -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal